
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
ERT has announced new reporting capabilities that help clinical trial sponsors and CROs ensure data collection during current global stay-home mandates. The Dashboard integrates data on coronavirus infection rates in geographic areas surrounding study investigative sites, so sponsors can identify and intervene where patient and site compliance to study protocols may be at risk.
For more information, click






